Isolated culture method of malignant pleural effusion-sourced TIL cells
A technology for separation and cultivation of malignant pleural effusion, applied in the field of separation and cultivation of TIL cells, which can solve the problems of complicated operations, shortened time spent on the separation and cultivation of TIL cells, and decreased cell viability, etc., and achieves strong tumor killing activity, increased pertinence, and separation and cultivation The effect of simple method
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] The malignant pleural effusion of a liver cancer patient (female, 48 years old) is now taken as the material for preparing tumor-specific TIL cells. The isolation and culture process of tumor-specific TIL cells is as follows:
[0038] Step 1: Preparation of single cell suspension.
[0039] 1.2 Wash the pleural effusion twice with D-Hanks solution, add an appropriate amount of PBS buffer solution (containing 0.5% BSA, 2 mmol EDTA, pH 7.2) to the precipitated cells, and separate the mononuclear cells with Ficoll lymphocyte separation medium. After counting, resuspend in PBS buffer solution, The final single-cell suspension of tumor tissue was obtained.
[0040] Step 2: Separate and obtain tumor-specific TIL cells by immunomagnetic bead technology.
[0041] 2.1 Adjust the final cell concentration obtained in step 1 to 2.5×10 per 1.0ml of buffer solution 8 cells.
[0042] 2.2 Add 100 ul of Fc receptor blocker (Miltenyi Biotec, product number 130-059-901), mix well, and p...
Embodiment 2
[0058] The malignant pleural effusion of a colorectal cancer patient (male, 53 years old) is now taken as the material for preparing tumor-specific TIL cells. The isolation and culture process of tumor-specific TIL cells is as follows:
[0059] Step 1 and step 3 are with embodiment 1;
[0060] The operation process of step 2 is the same as that of Example 1, the antibody added in step 2.4 is different, it is Anti-TIM-3-APC (Miltenyi Biotec, catalog number 130-098-936); the magnetic beads added in step 2.6 are different, are anti-APC magnetic beads (Miltenyi Biotec, Cat. No. 130-090-855).
Embodiment 3
[0062] The malignant pleural effusion of a colorectal cancer patient (female, 58 years old) was used as the material for preparing tumor-specific TIL cells. The isolation and culture process of tumor-specific TIL cells was as follows:
[0063] Step 1 and step 3 are with embodiment 1;
[0064] The operation process of step 2 is the same as that of Example 1, the differences are: the antibody added in step 2.4 is different, it is a mouse anti-human LAG-3 antibody (R&D SYSTEMS, article number: MAB23193, IgG1); the magnetic field added in step 2.6 Beads are different, anti-mouse IgG1 magnetic beads (Miltenyi Biotec, Cat. No. 130-047-101)
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com